<img alt="" src="https://secure.liod1ours.com/160545.png" style="display:none;">
Get a demo

QMAC dRAST™

- SIMPLIFY YOUR AST WORKFLOW

dRAST™ IS A RAPID AST PLATFORM AND CAN IDENTIFY OPTIMAL ANTIMICROBIAL AFTER

A POSITIVE BLOOD CULTURE, WHILE OTHER CONVENTIONAL SYSTEMS TAKE 2-3 DAYS.

 

Learn More   Get a demo

 

AS FEATURED ON
eccmid-full 01677012 antimicrobial chemotherapy medica_logo_k
 

EXPERIENCE THE POWER OF dRAST’S RANDOM ACCESS CAPABILITY AND IMPROVE YOUR LABORATORY TURN-AROUND TIME

 

FAST

Rapid AST with
MIC & SIR direct from PBC

 

 

 

COMPREHENSIVE

Full Expert System on board
with dynamic algorithm

 

 

EASY

Easy to use interface
with low hands-on time

Skærmbillede 2020-05-18 kl. 11.17.12

 

 

RANDOM ACCESS

Continuous loading for optimal handling of urgent care patients

 

 

 

FLEXIBLE

Incorporationg international guidelines & recommendations: EUCAST, CLSI & CA-SFM

 

 

CONNECTED

LIS BI-directional with easy Bacteria
Identification integration

 

dRAST™ HELPS SAVE THE LOVE OF MANY WHO SUFFER FROM LIFE-THREATENING INFECTIOUS DISEASES BY PROVIDING ANTIMICROBIAL SUSPECTIBILITY RESULTS 2 DAYS FASTER THAN CONVENTIONAL METHODS 

ezgif.com-video-to-gif

 

An overall combined CA for both GNs and GPs of 96.3%. The presented time to report data obtained by QMAC-dRASTTM in this study being of 3-8 hours for blood-culture specimens examined strongly support a further possible improvement in the workflow for handling blood stream infections.

Skærmbillede 2020-06-02 kl. 11.27.01
Jens Jørgen Christensen, clinical professor
The regional department of clinical microbiology, Zeeland University Hospital
Reporting based on MALDI-TOF MS results on susceptible/resistant pathogens, optimal targeted treatment was found respectively in 79%/63%, unnecessary broad-spectrum treatment in 16%/5%, suboptimal treatment in 4%/1%, and appropriate antibiotic treatment 100%/68%. Adding QMAC-dRAST results to the decision making raised the percentage of optimal antibiotic treatments to 98.2%
temp-avatar
Kim J-H
Chemother. 2019 Aug;74(8):2255–60.

Skærmbillede 2020-05-18 kl. 11.35.13

 

 

PATENDED 96 WELLS PLATE WITH DRIED ANTIBIOTICS

FEATURE

Gram Positive / Gram Negative panels for positive blood culture

 

GRAM POSITIVE & NEGATIVE
 

REPORTING SUSCEPTIBILITY BY PRORIETARY ALGORITM AND DATABASE

FEATURE
Automated image processing for growth measurement.
S I R(Susceptible, Intermediate and Resistant) determination based on database and expert rules in collaboration with EUCAST.
 
 
Keep updated on Eucast
Skærmbillede 2020-05-18 kl. 11.49.50

LESS LOADING MORE EFFICIENCY

 

NO SUB-CULTURE

By eliminating requirement for sub-cultures, dRAST improves your lab efficiency by reducing TAT for Antibiotic Susceptibility testing

 

NO McFARLAND

dRAST system does not require turbidity measurements

 

dRAST™ is the solution to help you care about Sepsis patients

1-improve-patient-health

 

2-Innovative-solutions-1
3-reducing-healthcare-cost

4-contribute

FREQUENTLY ASKED QUESTONS

 

On Gram Negative

 

On Gram Positive